OFIX Stock Analysis: Buy, Sell, or Hold?
OFIX - Orthofix Medical Inc. Common Stock (DE)
$11.61
0.14 (1.22%)
▲
5d:
-2.68%
30d:
-10.9%
90d:
-24.27%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When OFIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OFIX trading at deep discount. Market pricing in -18.7% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: OFIX trading at deep discount. Market pricing in -18.7% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.62
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.85
55.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OFIX is currently trading at $11.61, which is considered oversold relative to its 30-day fair value range of $11.61 to $12.94. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.6) compared to its historical average (25.2). Remarkably, the market is currently pricing in an annual earnings decline of 18.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OFIX is in a strong downtrend. Immediate support is located at $11.13, while resistance sits at $12.28.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.25 (+48.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OFIX is in a strong downtrend. Immediate support is located at $11.13, while resistance sits at $12.28.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.25 (+48.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$11.61 -
$12.94
Company Quality Score
61/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.6% below Wall St target ($17.25)
Fair Price Analysis
30-Day Fair Range
$11.61 -
$12.94
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.78
(6.7%)
Support & Resistance Levels
Support Level
$11.13
Resistance Level
$12.28
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.58
Wall Street Target
$17.25
(+48.6%)
Revenue Growth (YoY)
2.0%
Profit Margin
-11.2%
Valuation Discount vs History
-18.7% cheaper
PE vs Historical
13.6 vs 25.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.7%
(market-implied from PE analysis)
1-Year Target
$10.45
(-10%)
2-Year Target
$9.40
(-19%)
3-Year Target
$8.46
(-27%)
3-Yr Target (if PE normalizes)
(PE: 14→25)
$15.71
(+35%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 470.0%)
$64.49
(+456%)
Base:
(SPY PE: 13.6, Growth: 470.0%)
$39.18
(+238%)
Bear:
(PE: 11.5, Growth: 470.0%)
$33.31
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.6 to 25.2
Stabilization Target:
$21.55
(+85.6%)
PE Expansion Potential:
+85.6%
Share & Embed Analysis
Last updated: April 02, 2026 7:36 AM ET
Data refreshes hourly during market hours. Next update: 8:36 AM
Data refreshes hourly during market hours. Next update: 8:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OFIX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Engine Capital Managemen…
BUY
13061 shares
2026-02-25
Engine Capital Managemen…
BUY
124797 shares
2026-02-24
Julie Andrews
SELL
4873 shares
2026-01-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 54 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
